Authors


Bradley S. Stolshek, PharmD

Latest:

Etanercept and Ustekinumab Dosing for Psoriasis and Psoriatic Arthritis

For patients with psoriasis and/or psoriatic arthritis, actual-to-expected dosing ratios and costs were lower for etanercept than for ustekinumab.


Chelsey Kennedy, PharmD Candidate

Latest:

Vitamin D Deficiency and Patient Education

Pharmacists should be aware of the risk factors and signs of vitamin D deficiency to identify patients who would benefit the most from counseling and education.


MHA Specialty Pharmacy Solutions

Latest:

Engage and Consult: a Service Model Designed to Enable Success

Choosing the right partner in this dynamic environment is an important decision for all stakeholders.


Sherwanna Clarke, PharmD

Latest:

Statin-Fenofibrate Combination Therapy in an ACCORD Population: A Retrospective Analysis

Retrospective analysis of a population meeting criteria for the ACCORD lipid trial supported adjunct fenofibrate in patients with reduced low-density lipoprotein cholesterol and elevated triglycerides.


Lauren Simko, PharmD

Latest:

Guide to Discussing Influenza Vaccine With Patients

Pharmacists, being easily accessible to the community, can offer a unique perspective when discussing the flu vaccine.



Rashad Carlton, PharmD, MSPH

Latest:

Cost-Effectiveness of Fingolimod in Treating Patients With Relapsing-Remitting Multiple Sclerosis

Fingolimod, a first-line, once-daily oral disease-modifying therapy for relapsing-remitting multiple sclerosis, has the lowest cost per relapse avoided compared with other first-line agents.


Beth Greck, PharmD, CDE, BCACP

Latest:

Patient Characteristics' Effect on the Conversion Between Basal Insulins

The characteristics of patients who require increases in their basal insulin dose were compared with those requiring no increase following conversion between basal insulin analogues.


Amanda Hickman, PharmD, MPH

Latest:

High-Touch Specialty Pharmacy Services Improve Migraine Medication Access and Affordability

The underlying purpose of a study presentation that won the Top Poster Award at the 2019 National Association of Specialty Pharmacy Annual Meeting and Expo in Washington, DC, was to assess whether high-touch, clinic-based specialty pharmacy services could positively affect the affordability of self- and provider-administered migraine medications for patients.



Dustin Salyer, PharmD

Latest:

Community Retail Pharmacy: An Evolving and Rewarding Career

If your perception of life as a community retail pharmacist is that it is simply time spent counting by 5s, nothing could be further from the truth.


Jean Covino, DHSc, MPA, PA-C

Latest:

Clinicians, Pharmacists Should Work to Ensure Safety Compounded GLP-1 Medications

Pharmacists can educate patients about how to recognize unsafe online sources of medications and ensure patients are properly educate on how to administer their medications.



Kara L. Guarini, MS

Latest:

Workplace Wellness: Promoting a Culture That Benefits Companies and Employees

Approximately 155 million people in the United States under the age of 65 years receive employment-based health benefits.


Joe Moose, PharmD

Latest:

Implementing Critical Pathways of Clinical Care at Moose Pharmacy

Why are we implementing critical pathways for care delivery? Because I want Moose Pharmacy to be around another century and a half.


Ashley Marx, PharmD, BCPS

Latest:

Antimicrobial Stewardship Efforts Advance in US Health Systems

Recently released action plans detail procedures to combat antimicrobial resistance.


Marc Stranz, PharmD, Chief Clinical Officer, BioMatrix Specialty Pharmacy

Latest:

Should Pharmacists Refill a Prescription if the Prescriber's License is Inactive?

Most state pharmacy regulations do not specifically require verification of the prescriber’s license prior to dispensing.



Jeoffrey Stross, MD

Latest:

Enhancing the Strategy for Specialty Pharmaceuticals

Strategies for controlling use of specialty pharmaceuticals should focus on situations where these agents are used inappropriately and on improvement of the complex billing process.


Sujit S. Sansgiry, PhD

Latest:

Medicare Part D Insulin Tiering Change: Impact on Health Outcomes

This study explores the impact of a Medicare Part D formulary tier change, specifically with respect to branded insulin products, on insulin adherence, hemoglobin A1C, and diabetes-related events in elderly diabetic beneficiaries strategies for selection of appropriate and cost-effective therapy will also be discussed.



Usha Sambamoorthi, PhD

Latest:

Medicare Claim Processors' Reimbursement and G-CSF Choice Among Non-Hodgkin Lymphoma Patients

Using the SEER-Medicare database, we found negative association between Medicare claim processors“related physician's chemotherapy reimbursement and their prescription of granulocyte colony-stimulating factor for non-Hodgkin lymphoma patients.



Stacey Ness, PharmD

Latest:

Specialty Pharmacy Management of Gout

New drugs and drugs in the pipeline for gout have changed the treatment for this painful disease, one of the oldest documented diseases. Here's an update on what's new and what specialty pharmacists need to know as they counsel patients for gout.


Nadia Krasner, PhD

Latest:

Increases in Utilization Management of Oncology Medicines by US Payers

Recent increases in the number of therapies indicated for a given oncology subtype has resulted in heightened utilization management stringency.


Adam Pate, PharmD, BCPS

Latest:

Smoking Cessation: Overcoming Nicotine Dependence

Pharmacists can learn about the available interventions for smoking cessation.


Marc O'Connor

Latest:

The Missing Link: Care Management’s Ability to Improve Specialty Pharmacy’s Value Proposition

A real-life look at pharmacist-led care management's ability to overcome barriers to care and adherence in HIV treatment.


Ngoc-Linh Nguyen, PharmD Candidate

Latest:

Summary of Current SARS-CoV-2 Vaccine Trials

Many clinical trials are underway in a race to develop a safe and effective vaccine against severe acute respiratory SARS-CoV-2, the virus that causes COVID-19.


Max Greenlee, 2016 PharmD candidate

Latest:

Diabetes and Sodium-Glucose Cotransporter-2 Inhibitors

Diabetes is a disease that affects a person's life each day by having a negative effect on quality of life and creating a financial burden for patients and families.


Kristen Coppock, MA, Editor

Latest:

16 New Investigators Awarded AACP Grants

Sixteen new investigator award (NIA) winners are receiving up to $10,000 in grants from the American Association of Colleges of Pharmacy.